Updated:2025-01-06 04:12 Views:93
Plenty of big news happened in 2024. A top presidential candidate dropped out of the race late; another survived two assassination attempts; and voters rejected the incumbent administration at the ballot box. This year also included conflicts abroad, the Summer Olympics and two (yes, two) Emmy Award ceremonies.
But between these major flash points were hundreds of smaller moments.
While viral videos like “demure” and beloved animals like Moo Deng were virtually unavoidable — and quickly became part of mainstream culture — it’s possible you didn’t hear about “yapping” or know that another Pygmy hippo, named Haggis, was also born this year.
Maybe you can’t forget that you, in fact, “exist in the context of all in which you live and what came before you,” but are you “holding space” for P’Nut the squirrel? (And if you can comprehend that sentence, you might have “brain rot.”)
This is the year in micro news, an attempt to burst your algorithmic bubble and remind you of everything you already forgot about — or maybe never knew about in the first place.
The OlympicImageWe are having trouble retrieving the article content.
Please enable JavaScript in your browser settings.
Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.
Thank you for your patience while we verify access.
huuuge casino slots vegas 777Already a subscriber? Log in.
AstraZeneca, which makes the treatment, said it would start a FluMist Home website, where people can fill out a questionnaire that will be reviewed by a pharmacist before the treatment is shipped to a person’s home. The mist will remain available from prescribers as an in-office treatment. The current out-of-pocket cost for a dose is about $35 to $45, but may be less depending on insurance coverage.
Agency officials said they had filed an administrative complaint, which is not yet public, that accuses the P.B.M.s of distorting competition and harming consumers. The agency is seeking to prohibit the benefit managers from favoring medicines because those drugs make them more money.
Want all of The Times? Subscribe.haha777